Kajihara Y et al. |
Analysis of the cost-effectiveness of using vonoprazan-amoxicillin-clarithromycin triple therapy for first-line Helicobacter pylori eradication. |
2017 |
Scand. J. Gastroenterol. |
pmid:27806639
|
Shaulov A et al. |
Progressive refractory light chain amyloidosis and multiple myeloma patients are responsive to the addition of clarithromycin to IMiD based therapy. |
2017 |
Am. J. Hematol. |
pmid:27804150
|
Malfertheiner P et al. |
Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. |
2017 |
Gut |
pmid:27707777
|
Reddy AB and Reddy ND |
Development of Multiple-Unit Floating Drug Delivery System of Clarithromycin: Formulation, in vitro Dissolution by Modified Dissolution Apparatus, in vivo Radiographic Studies in Human Volunteers. |
2017 |
Drug Res (Stuttg) |
pmid:28449156
|
Aktas AH and Saridag AM |
Liquid Chromatographic-Chemometric Techniques for the Simultaneous HPLC Determination of Lansoprazole, Amoxicillin and Clarithromycin in Commercial Preparation. |
2017 |
J Chromatogr Sci |
pmid:28449104
|
Itskoviz D et al. |
Smoking increases the likelihood of Helicobacter pylori treatment failure. |
2017 |
Dig Liver Dis |
pmid:28427781
|
Koštrun S et al. |
Around the macrolide - Impact of 3D structure of macrocycles on lipophilicity and cellular accumulation. |
2017 |
Eur J Med Chem |
pmid:28410508
|
Berni E et al. |
Risk of cardiovascular events, arrhythmia and all-cause mortality associated with clarithromycin versus alternative antibiotics prescribed for respiratory tract infections: a retrospective cohort study. |
2017 |
BMJ Open |
pmid:28115334
|
Costa S et al. |
Efficacy and tolerability of culture-guided treatment for Helicobacter pylori infection. |
2017 |
Eur J Gastroenterol Hepatol |
pmid:28877088
|
Pryjma M et al. |
Antagonism between Front-Line Antibiotics Clarithromycin and Amikacin in the Treatment of Mycobacterium abscessus Infections Is Mediated by the Gene. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28874379
|
Takahashi C et al. |
Morphological study of efficacy of clarithromycin-loaded nanocarriers for treatment of biofilm infection disease. |
2017 |
Med Mol Morphol |
pmid:27119723
|
Ruiter R et al. |
Helicobacter pylori resistance in the Netherlands: a growing problem? |
2017 |
Neth J Med |
pmid:29219812
|
Ramas M et al. |
Efficacy and safety of rifaximin associated with standard triple therapy (omeprazole, clarithromycin and amoxicillin) for H. pylori eradication: A phase IV pilot clinical trial. |
2017 |
Gastroenterol Hepatol |
pmid:28780968
|
Painsi C and Lange-Asschenfeldt B |
Image Gallery: Pink papules within a tattoo linked to Mycobacterium chelonae infection. |
2017 |
Br. J. Dermatol. |
pmid:28731256
|
Mougari F et al. |
Selection of Resistance to Clarithromycin in Mycobacterium abscessus Subspecies. |
2017 |
Antimicrob. Agents Chemother. |
pmid:27799212
|
Sharman MJ et al. |
Gastrokine mRNA expression in gastric tissue from dogs with helicobacter colonisation but without inflammatory change during treatment. |
2017 |
Vet. Immunol. Immunopathol. |
pmid:28494926
|
O'Brien CR et al. |
Feline leprosy due to Candidatus 'Mycobacterium tarwinense':Further clinical and molecular characterisation of 15 previously reported cases and an additional 27 cases |
2017 |
J. Feline Med. Surg. |
pmid:28438086
|
Chang JY et al. |
Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication. |
2017 |
BMC Gastroenterol |
pmid:28109257
|
Sasaoka Y et al. |
Neonatal apnea with Chlamydia pneumoniae infection. |
2017 |
Pediatr Int |
pmid:28102626
|
Lapa GB et al. |
Two approaches to the use of benzo[c][1,2]oxaboroles as active fragments for synthetic transformation of clarithromycin. |
2017 |
J Enzyme Inhib Med Chem |
pmid:28097898
|